In this video, Fool.com contributors John Reeves and David Meier sit down and talk about the two biggest holdings in David's portfolio. He shares with investors how his investing style has shifted over the years, and why InvenSense (INVN) and Infinera (INFN) both represent incredible disruptive opportunities, and why he sees them as two of the next great companies on the market.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
My Top Two Stocks: InvenSense and Infinera
NYSE: INVN
InvenSense, Inc.

Fool analyst David Meier shares with investors why these two stocks are at the top of his portfolio.
David Meier owns shares of MAKO Surgical, InvenSense, and Infinera. John Reeves has no position in any stocks mentioned. The Motley Fool recommends Infinera and MAKO Surgical. The Motley Fool owns shares of Infinera and InvenSense. The Motley Fool is short InvenSense. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned



*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.